SCHEMBL5686191

SCHEMBL5686191

Cc1cccc(C)c1NC(=O)c1cnc(Nc2ccc(N3CCN(C)CC3)c(OC(F)F)c2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIK1 P57059 2/20 0.51
SIK2 Q9H0K1 2/20 0.51
SIK3 Q9Y2K2 2/20 0.51
BRD4 O60885 1/20 0.46
JAK1 P23458 1/20 0.46
PAK1 Q13153 4/20 0.46
SRC P12931 2/20 0.46
LCK P06239 5/20 0.45
KDR P35968 5/20 0.45
MAPK14 Q16539 5/20 0.45
FGFR3 P22607 3/20 0.44
TEK Q02763 2/20 0.44
ABL1 P00519 1/20 0.44
FYN P06241 1/20 0.44
CSF1R P07333 1/20 0.44
LYN P07948 1/20 0.44
MAPK9 P45984 1/20 0.44
JAK3 P52333 1/20 0.43
EGFR P00533 1/20 0.43
BTK Q06187 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4504797 0.90 PAK1 (0.57) SIK1SIK2SIK3PAK1SRC
SCHEMBL4484592 0.86 SIK1 (0.66) SIK1SIK2SIK3BRD4JAK1
SCHEMBL4489088 0.82 TNK2 (0.63) SIK1SIK2SIK3BRD4PAK1
SCHEMBL4489918 0.80 LCK (0.63) BRD4SRCLCKKDRMAPK14
SCHEMBL4494799 0.79 SIK1 (0.47) SIK1SIK2SIK3BRD4JAK1
SCHEMBL5689693 0.77 SRC (0.46) SIK1SIK2SIK3SRCEGFR
SCHEMBL5689137 0.76 KDR (0.53) BRD4SRCLCKKDRMAPK14
SCHEMBL4496504 0.76 KDR (0.52) SIK1SIK2SIK3SRCLCK
SCHEMBL4499210 0.75 SIK1 (0.56) SIK1SIK2SIK3BRD4JAK1
SCHEMBL4506989 0.75 LCK (0.58) SIK1SIK2SIK3PAK1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed